Centene (CNC) Competitors $31.77 -0.40 (-1.24%) Closing price 09/19/2025 03:59 PM EasternExtended Trading$31.92 +0.16 (+0.49%) As of 09/19/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CNC vs. ELV, MOH, SEM, HUM, UNH, CI, JYNT, AEMD, REGN, and ALNYShould you be buying Centene stock or one of its competitors? The main competitors of Centene include Elevance Health (ELV), Molina Healthcare (MOH), Select Medical (SEM), Humana (HUM), UnitedHealth Group (UNH), Cigna Group (CI), Joint (JYNT), Aethlon Medical (AEMD), Regeneron Pharmaceuticals (REGN), and Alnylam Pharmaceuticals (ALNY). These companies are all part of the "medical" sector. Centene vs. Its Competitors Elevance Health Molina Healthcare Select Medical Humana UnitedHealth Group Cigna Group Joint Aethlon Medical Regeneron Pharmaceuticals Alnylam Pharmaceuticals Centene (NYSE:CNC) and Elevance Health (NYSE:ELV) are both large-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, profitability, dividends, institutional ownership, risk and earnings. Do analysts prefer CNC or ELV? Centene presently has a consensus target price of $38.33, suggesting a potential upside of 20.66%. Elevance Health has a consensus target price of $411.06, suggesting a potential upside of 30.95%. Given Elevance Health's stronger consensus rating and higher probable upside, analysts plainly believe Elevance Health is more favorable than Centene.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Centene 1 Sell rating(s) 13 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.12Elevance Health 0 Sell rating(s) 6 Hold rating(s) 12 Buy rating(s) 0 Strong Buy rating(s) 2.67 Do institutionals & insiders hold more shares of CNC or ELV? 93.6% of Centene shares are owned by institutional investors. Comparatively, 89.2% of Elevance Health shares are owned by institutional investors. 0.4% of Centene shares are owned by company insiders. Comparatively, 0.3% of Elevance Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has more volatility & risk, CNC or ELV? Centene has a beta of 0.44, suggesting that its stock price is 56% less volatile than the S&P 500. Comparatively, Elevance Health has a beta of 0.59, suggesting that its stock price is 41% less volatile than the S&P 500. Which has preferable valuation and earnings, CNC or ELV? Elevance Health has higher revenue and earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Elevance Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCentene$163.07B0.10$3.31B$4.047.86Elevance Health$177.01B0.40$5.98B$23.5013.36 Does the media favor CNC or ELV? In the previous week, Centene had 3 more articles in the media than Elevance Health. MarketBeat recorded 27 mentions for Centene and 24 mentions for Elevance Health. Elevance Health's average media sentiment score of 1.36 beat Centene's score of 0.91 indicating that Elevance Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Centene 18 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Elevance Health 20 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is CNC or ELV more profitable? Elevance Health has a net margin of 2.83% compared to Centene's net margin of 1.15%. Elevance Health's return on equity of 17.59% beat Centene's return on equity.Company Net Margins Return on Equity Return on Assets Centene1.15% 9.57% 3.10% Elevance Health 2.83%17.59%6.36% SummaryElevance Health beats Centene on 13 of the 16 factors compared between the two stocks. Get Centene News Delivered to You Automatically Sign up to receive the latest news and ratings for CNC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CNC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CNC vs. The Competition Export to ExcelMetricCenteneMED IndustryMedical SectorNYSE ExchangeMarket Cap$15.80B$48.97B$5.79B$21.65BDividend YieldN/A2.01%5.63%3.51%P/E Ratio7.869.7576.4829.96Price / Sales0.101.03531.9560.86Price / Cash3.258.5837.9224.97Price / Book0.612.2613.724.59Net Income$3.31B$2.64B$3.29B$999.97M7 Day Performance-4.31%-3.63%1.03%0.91%1 Month Performance8.41%-4.20%6.32%5.36%1 Year Performance-57.99%-38.39%81.16%14.36% Centene Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CNCCentene4.9285 of 5 stars$31.77-1.2%$38.33+20.7%-58.0%$15.80B$163.07B7.8660,500ELVElevance Health4.9124 of 5 stars$306.87-1.6%$411.06+34.0%-41.7%$69.10B$177.01B13.06104,200Positive NewsMOHMolina Healthcare4.7987 of 5 stars$176.34-2.5%$225.18+27.7%-50.0%$9.56B$43.41B8.6918,000Positive NewsShort Interest ↑SEMSelect Medical4.9978 of 5 stars$12.25-2.1%$19.20+56.7%-65.0%$1.52B$5.19B11.5644,100HUMHumana4.7476 of 5 stars$274.75-0.6%$289.24+5.3%-19.1%$33.04B$117.76B21.0965,680Positive NewsUNHUnitedHealth Group4.9416 of 5 stars$348.05-0.6%$358.95+3.1%-41.7%$315.22B$422.82B15.08400,000Positive NewsShort Interest ↓CICigna Group5 of 5 stars$297.31-1.8%$374.76+26.1%-18.8%$79.36B$259.42B16.2373,500Positive NewsJYNTJoint3.7566 of 5 stars$9.98-0.8%$16.33+63.7%-16.3%$153.12M$53.45M-30.24320AEMDAethlon Medical1.4997 of 5 stars$0.73-5.4%$56.00+7,559.7%-76.7%$1.90MN/A-0.0610REGNRegeneron Pharmaceuticals4.7527 of 5 stars$572.59+2.2%$817.67+42.8%-48.5%$60.69B$14.21B14.4315,106Positive NewsShort Interest ↑ALNYAlnylam Pharmaceuticals3.8839 of 5 stars$461.14-1.0%$421.28-8.6%+64.1%$60.45B$2.25B-186.702,230Trending NewsAnalyst Forecast Related Companies and Tools Related Companies ELV Alternatives MOH Alternatives SEM Alternatives HUM Alternatives UNH Alternatives CI Alternatives JYNT Alternatives AEMD Alternatives REGN Alternatives ALNY Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CNC) was last updated on 9/20/2025 by MarketBeat.com Staff From Our PartnersPrepare for the “Mar-a-Lago Accord” Money ShockWhy Are Wall Street Insiders Moving Their Money to This ONE Asset? Something far more consequential for you...Stansberry Research | SponsoredWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | SponsoredREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Centene Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Centene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
